Latest Unjha Formulations stock price
Unjha Formulations P/E Ratio
UNJHAFOR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
26.34
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
26.34
Current Price
₹23.97
EPS (TTM)
₹0.91
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.4
Sector Median
31.12
Sector Rank
#11 of 132
Sector Percentile
8.3%
Key P/E Ratio Insights for Unjha Formulations
- Stock appears overvalued with PE of 26.34, suggesting caution for new investments
- Trading at discount to sector average PE of 53.4
View the UNJHAFOR equity price for detailed stock performance.
Related Pages for Unjha Formulations
Additional stock information and data for UNJHAFOR
Sector P/E Ratio Comparison
Comparing Unjha Formulations with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |